newsfilter
← Latest News
PR Newswire·

Inhibrx Biosciences Announces Departure of CSO and Appointments of New CSO and President

Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company"), a clinical-stage biopharmaceutical company with two programs in clinical-stage ...